)
Kevin Beck
Head of Commercial, Viral Vector CDMO,
Millipore Sigma
With over 20 years of expertise in cell and gene therapy, Kevin D. Beck, Ph.D. currently leads the commercial team for the Viral Vector CDMO business. In this role, he is dedicated to supporting clients in advancing their cell and gene therapies through comprehensive development and manufacturing services. Dr. Beck earned his Ph.D. in Biological Sciences from UC Irvine and further honed his skills as a post-doctoral fellow at UC San Diego where he researched the mechanisms of differentiation and function of T regulatory cells. His industrial career began with a technical focus on analytics, which seamlessly evolved into commercial roles, emphasizing the transformative potential of cell and gene therapy.